The FDA recently requested the withdrawal from the public market of Xiadafil VIP tabs, an erectile dysfunction drug, due to health problems caused by an undeclared ingredient contained within this “all-natural” dietary supplement. The State of Florida has requested the action be taken against the sale or marketing of Xiadafil VIP tabs, which contain hydroxyhomosildenafil, an analog of sildenafil, the active ingredient in Viagra. Unwitting consumers are likely unaware of the potential risks caused by reactions between this active ingredient and prescription drugs commonly taken by men with ED.
Viagra and other FDA-approved treatments for ED contain recognized, FDA-tested active ingredients, and users are generally advised on the possible side effects and contraindications by their doctor. However, by marketing Xiadafil as a “natural” supplement, manufacturer SEI Pharmaceuticals hoped to circumvent medical intervention, thus opening the floodgates for men to receive desperately wanted treatment for their ED problem without having to see a doctor.
The effects of the undeclared active ingredient in Xiadafil occur when it combines with nitrates, commonly used to treat heart problems, high blood pressure and diabetes, and may cause a life-threatening drop in blood pressure.
If you have been affected in any way by unsafe drugs such as Xiadafil, Heparin or Paxil, Carr & Carr, Attorneys at Law, can offer you expert legal advice in Arkansas and Tulsa and Oklahoma City, Oklahoma.
Posted by Patti
Related posts:
- Contaminated Dietary Supplements May Cause Health Risks
- FDA Issues Alli And Xenical Warning
- Recalls 34 Dietary Weight Loss Supplements
- FDA Orders Recall of Isosorbide Mononitrate Extended Release Tablets
Tags: defective drugs
